Association of germline variant status with therapy response in high-risk early-stage breast cancer: a secondary analysis of the geparOcto randomized clinical trial

Saved in:

Bibliographic Details
Main Authors:	Pohl-Rescigno, Esther (Author) , Hauke, Jan (Author) , Loibl, Sibylle (Author) , Möbus, Volker (Author) , Denkert, Carsten (Author) , Fasching, Peter A. (Author) , Kayali, Mohamad (Author) , Ernst, Corinna (Author) , Weber-Lassalle, Nana (Author) , Hanusch, Claus (Author) , Tesch, Hans (Author) , Müller, Volkmar (Author) , Altmüller, Janine (Author) , Thiele, Holger (Author) , Untch, Michael (Author) , Lübbe, Kristina (Author) , Nürnberg, Peter (Author) , Rhiem, Kerstin (Author) , Furlanetto, Jenny (Author) , Lederer, Bianca (Author) , Jackisch, Christian (Author) , Nekljudova, Valentina (Author) , Schmutzler, Rita K. (Author) , Schneeweiss, Andreas (Author) , Hahnen, Eric (Author)
Format:	Article (Journal) Editorial
Language:	English
Published:	March 12, 2020
In:	JAMA oncology Year: 2020, Volume: 6, Issue: 5, Pages: 744-748
ISSN:	2374-2445
DOI:	10.1001/jamaoncol.2020.0007
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaoncol.2020.0007 Verlag, lizenzpflichtig, Volltext: https://jamanetwork.com/journals/jamaoncology/fullarticle/2762579
Author Notes:	Esther Pohl-Rescigno, PhD, Jan Hauke, PhD, Sibylle Loibl, MD, Volker Möbus, MD, Carsten Denkert, MD, Peter A. Fasching, MD, Mohamad Kayali, BSc, Corinna Ernst, BSc, Nana Weber-Lassalle, BSc, Claus Hanusch, MD, Hans Tesch, MD, Volkmar Müller, MD, Janine Altmüller, MD, Holger Thiele, MD, Michael Untch, MD, Kristina Lübbe, MD, Peter Nürnberg, PhD, Kerstin Rhiem, MD, Jenny Furlanetto, MD, Bianca Lederer, PhD, Christian Jackisch, MD, Valentina Nekljudova, PhD, Rita K. Schmutzler, MD, Andreas Schneeweiss, MD, Eric Hahnen, PhD

Description
Item Description:	Gesehen am 01.04.2021
Physical Description:	Online Resource
ISSN:	2374-2445
DOI:	10.1001/jamaoncol.2020.0007